ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $25,000,000 | +3113.4% | 5,000,000 | +15065.3% | 0.52% | +1646.7% |
Q3 2015 | $778,000 | -54.5% | 32,970 | +57.8% | 0.03% | -47.4% |
Q2 2015 | $1,709,000 | +636.6% | 20,900 | +736.0% | 0.06% | +612.5% |
Q1 2015 | $232,000 | – | 2,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,679,835 | $99,609,000 | 22.32% |
Bellevue Group AG | 5,465,715 | $203,160,000 | 2.81% |
Rhenman & Partners Asset Management AB | 455,000 | $16,912,000 | 1.50% |
Endurant Capital Management LP | 135,901 | $5,051,000 | 1.49% |
Boxer Capital, LLC | 975,000 | $36,241,000 | 1.25% |
DCF Advisers, LLC | 56,500 | $2,100,000 | 1.07% |
Pentwater Capital Management LP | 2,169,022 | $80,623,000 | 1.04% |
Nicholas Investment Partners, LP | 235,855 | $8,767,000 | 0.95% |
Amia Capital LLP | 20,464 | $761,000 | 0.88% |
HAMILTON LANE ADVISORS LLC | 46,181 | $1,717,000 | 0.83% |